Baricitinib is safe and effective for treatment of refractory juvenile idiopathic arthritis
1. Time to disease flare was significantly shorter in the placebo group versus baricitinib. 2. There was no difference in ...
Tag: psoriatic arthritis
Bimekizumab is effective for active psoriatic arthritis in biologic-naïve adults
1. Significantly more patients in the bimekizumab group reached ACR50 at week 16 compared to the placebo. 2. Fungal infections ...
#VisualAbstract: Tofacitinib reduces the rate of flare-ups in patients with polyarticular juvenile idiopathic arthritis
1. Patients in the tofacitinib group reported significantly fewer flare-ups (29%) compared to placebo (53%) by week 44. 2. The ...
Tofacitinib reduces the rate of flare-ups in patients with polyarticular juvenile idiopathic arthritis
1. Patients in the tofacitinib group reported significantly fewer flare-ups (29%) compared to placebo (53%) by week 44. 2. The ...
Upadacitinib non-inferior to adalimumab for psoriatic arthritis treatment
1. Janus kinase (JAK) inhibitor upadacitinib showed non-inferior efficacy in improving psoriatic arthritis compared to standard-of-care adalimumab. 2. High-dose upadacitinib ...
Patient Basics: Psoriatic Arthritis
Originally published by Harvard Health. What Is It? Psoriatic arthritis is a chronic (long-lasting) disease in which a person with ...
Brodalumab effective in treating active psoriatic arthritis
1. Brodalumab was found to produce a 20% improvement in various clinical domains for patients with active psoriatic arthritis by ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
